Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons

Nagai, Makiko, Re, Diane B, Nagata, Tetsuya, Chalazonitis, Alcmène, Jessell, Thomas M, Wichterle, Hynek, Przedborski, Serge·2007·Nature Neuroscience
DOI 10.1038/nn1876

Cited by (1,000)

Items 801–900 of 1,000

  1. Insights into Human-Induced Pluripotent Stem Cell-Derived Astrocytes in Neurodegenerative Disorders
    Mandeep Kumar, T. P. Nhung Nguyen, Marco Milanese, Giambattista Bonanno · 2022 · Biomolecules
  2. Role and Therapeutic Potential of RAGE Signaling in Neurodegeneration
    Mariana Pehar, Noah A. Kinscherf · 2022 · Current Drug Targets
  3. Retromer dysfunction in amyotrophic lateral sclerosis
    Eduardo J. Pérez-Torres, Irina V. Utkina-Sosunova, Vartika R. Mishra, Peter A. Barbuti, Mariangels De Planell-Saguer, Georgia Dermentzaki, Heather M. Geiger, Anna Okula Basile, Nicolas Robine, Delphine Fagegaltier et al. · 2022 · Proceedings of the National Academy of Sciences
  4. Dynamic Meta-Analysis as a Therapeutic Prediction Tool for Amyotrophic Lateral Sclerosis
    S. Cassie, Robert H. · 2012 · InTech eBooks
  5. Suppression of MAPK attenuates neuronal cell death induced by activated glia-conditioned medium in alpha-synuclein overexpressing SH-SY5Y cells
    Lidia Yshii, Alexandre Denadai‐Souza, Andréa Rodrigues Vasconcelos, Maria Christina W. Avellar, Cristóforo Scavone · 2015 · Journal of Neuroinflammation
  6. Astrocytes Regulate the Expression of Insulin-Like Growth Factor 1 Receptor (IGF1-R) in Primary Cortical Neurons During In Vitro Senescence
    Claudio Costantini, Erika Lorenzetto, Barbara Cellini, Mario Buffelli, Filippo Rossi, Vittorina Della Bianca · 2009 · Journal of Molecular Neuroscience
  7. Stem cells and the ALS neurologist
    Nicholas John Maragakis · 2010 · Amyotrophic Lateral Sclerosis
  8. The review of the methods to obtain non-neuronal cells to study glial influence on Amyotrophic Lateral Sclerosis pathophysiology at molecular level in vitro
    Juliana Milani Scorisa, Tatiana Duobles, G. P. de Oliveira, Jéssica Ruivo Maximino, Gerson Chadi · 2010 · Acta Cirúrgica Brasileira
  9. Glia as primary drivers of neuropathology in TDP-43 proteinopathies
    Steven A. Sloan, Ben A. Barres · 2013 · Proceedings of the National Academy of Sciences
  10. Generation of embryonic stem cells: limitations of and alternatives to inner cell mass harvest
    Sunit Das, Michael A. Bonaguidi, Kenji Muro, John A. Kessler · 2008 · Neurosurgical FOCUS
  11. Human stem cell grafts as therapies for motor neuron disease
    Vassilis E. Koliatsos, Leyan Xu, Jun Yan · 2008 · Expert Opinion on Biological Therapy
  12. Wnt Signaling Alteration in the Spinal Cord of Amyotrophic Lateral Sclerosis Transgenic Mice: Special Focus on Frizzled-5 Cellular Expression Pattern
    Carlos González‐Fernández, Renzo Mancuso, Jaume del Valle, Xavier Navarro, Francisco Javier Rodríguez · 2016 · PLoS ONE
  13. LRRK2 and the “LRRKtosome” at the Crossroads of Programmed Cell Death: Clues from RIP Kinase Relatives
    Rideout, Hardy J., Re, Diane B. · 2017 · Advances in Neurobiology
  14. Comparative effects of progesterone and the synthetic progestin norethindrone on neuroprotection in a model of spontaneous motoneuron degeneration
    Gisella M. Gargiulo-Monachelli, María Meyer, Agustina Lara, Laura I. Garay, Analia E. Lima, Paulina Roig, Alejandro Federico De Nicola, Marı́a Claudia González Deniselle · 2019 · The Journal of Steroid Biochemistry and Molecular Biology
  15. Inflammatory cytokines increase mitochondrial damage in motoneuronal cells expressing mutant SOD1
    Alberto Ferri, Monica Nencini, Mauro Cozzolino, Paolo Carrara, Sandra Moreno, Maria Teresa Carrı̀ · 2008 · Neurobiology of Disease
  16. Advances in Patient-Specific Induced Pluripotent Stem Cells Shed Light on Drug Discovery for Amyotrophic Lateral Sclerosis
    Jui-Hao Lee, Jen-Wei Liu, Shinn‐Zong Lin, Horng‐Jyh Harn, Tzyy‐Wen Chiou · 2018 · Cell Transplantation
  17. The Bcl-2 Homology-3 Domain (BH3)-Only Proteins, Bid, DP5/Hrk, and BNip3L, Are Upregulated in Reactive Astrocytes of End-Stage Mutant SOD1 Mouse Spinal Cord
    Duval, Nathan, Sumner, Whitney A., Andrianakos, Anna G., Gray, Josie J., Bouchard, Ron J., Wilkins, Heather M., Linseman, Daniel A. · 2018 · Frontiers in Cellular Neuroscience
  18. Cortical Hyperexcitability in the Driver’s Seat in ALS
    Zeynep I. Gunes, Vanessa W. Y. Kan, Shenyi Jiang, Evgeny Logunov, XiaoQian Ye, Sabine Liebscher · 2022 · Clinical and Translational Neuroscience
  19. Angiotensin II and aldosterone-induced neuronal damage in neurons through an astrocyte-dependent mechanism
    Li‐Juan Min, Masaki Mogi, Jun Iwanami, Akiko Sakata, Fei Jing, Kana Tsukuda, Kousei Ohshima, Masatsugu Horiuchi · 2011 · Hypertension Research
  20. Glutamate pathway implication in amyotrophic lateral sclerosis: what is the signal in the noise?
    Diane Bérangère Ré, Virginia Le Verche, Burcin Ikiz, Arnaud Jacquier, Serge Przedborski · 2010 · Journal of Receptor Ligand and Channel Research
  21. Neuroprotective effects of clarithromycin against neuronal damage in cerebral ischemia and in cultured neuronal cells after oxygen-glucose deprivation
    Yasuo Katayama, Toshiki Inaba, Chikako Nito, Satoshi Suda, Masayuki Ueda · 2016 · Life Sciences
  22. Methylcobalamin prevents mutant superoxide dismutase-1-induced motor neuron death in vitro
    Shunsuke Ito, Yukina Izumi, Tetsuhiro Niidome, Yuichi Ono · 2016 · Neuroreport
  23. Astrocyte-Like Cells Differentiated from Dental Pulp Stem Cells Protect Dopaminergic Neurons Against 6-Hydroxydopamine Toxicity
    Kavina Ganapathy, Indrani Datta, Ramesh Ramchandra Bhonde · 2018 · Molecular Neurobiology
  24. ALS, a cellular whodunit on motor neuron degeneration
    Peter Karagiannis, Haruhisa Inoue · 2020 · Molecular and Cellular Neuroscience
  25. Diabetes Mellitus and Amyotrophic Lateral Sclerosis: A Systematic Review
    Laura Ferri, Paola Ajdinaj, Marianna Gabriella Rispoli, Claudia Carrarini, Filomena Barbone, Damiano D’Ardes, Margherita Capasso, Antonio Di Muzio, Francesco Cipollone, MARCO C. ONOFRJ et al. · 2021 · Biomolecules
  26. An SMA Project Report: Neural Cell-Based Assays Derived from Human Embryonic Stem Cells
    Patricia G. Wilson, Jonathan J. Cherry, Shelle Schwamberger, Allison M. Adams, Jianhua Zhou, Soojung Shin, Steven L. Stice · 2007 · Stem Cells and Development
  27. High content analysis in amyotrophic lateral sclerosis
    Federica Rinaldi, Dario Motti, Laura Ferraiuolo, Brian K. Kaspar · 2016 · Molecular and Cellular Neuroscience
  28. Pre-symptomatic alterations in subcellular βCGRP distribution in motor neurons precede astrogliosis in ALS mice
    Cornelia Ringer, Eberhard Weihe, Burkhard Schütz · 2009 · Neurobiology of Disease
  29. Mature iPSC-derived astrocytes of an ALS/FTD patient carrying the TDP43A90V mutation display a mild reactive state and release polyP toxic to motoneurons
    Fabiola Rojas, Rodrigo Aguilar, Sandra Almeida, Elsa Fritz, Daniela Corvalán, Estíbaliz Ampuero, Sebastián Abarzúa, Polett Garcés, Armando Amaro, Iván Diaz et al. · 2023 · Frontiers in Cell and Developmental Biology
  30. Dual Role of Lysophosphatidic Acid Receptor 2 (LPA2) in Amyotrophic Lateral Sclerosis
    María Puigdomenech, Anna Martínez‐Muriana, Pol Andrés‐Benito, Isidró Ferrer, Jerold J. M. Chun, Rubén López‐Vales · 2021 · Frontiers in Cellular Neuroscience
  31. Targeting TNFα produced by astrocytes expressing amyotrophic lateral sclerosis‐linked mutant fused in sarcoma prevents neurodegeneration and motor dysfunction in mice
    Brigid K. Jensen, Kevin J. McAvoy, Nicolette M. Heinsinger, Angelo C. Lepore, Hristelina S. Ilieva, Aaron R. Haeusler, Davide Trotti, Piera Pasinelli · 2022 · Glia
  32. Modulation of SOD1 Subcellular Localization by Transfection with Wild- or Mutant-type SOD1 in Primary Neuron and Astrocyte Cultures from ALS Mice
    Do-Yeon Lee, Gye Sun Jeon, Yumi Shim, Seung‐Yong Seong, Kwang‐Woo Lee, Jung‐Joon Sung · 2015 · Experimental Neurobiology
  33. Combined excitotoxic–oxidative stress and the concept of non-cell autonomous pathology of ALS: Insights into motoneuron axonopathy and astrogliosis
    Nicole Wallis, Chrissandra J. Zagami, Philip M. Beart, Ross D. O’Shea · 2012 · Neurochemistry International
  34. Prognostic role of “prion-like propagation” in SOD1-linked familial ALS: an alternative view
    Keizo Sugaya, Imaharu Nakano · 2014 · Frontiers in Cellular Neuroscience
  35. Acute glial activation by stab injuries does not lead to overt damage or motor neuron degeneration in the G93A mutant SOD1 rat model of amyotrophic lateral sclerosis
    Masatoshi Suzuki, Sandra M. Klein, Elizabeth A. Wetzel, Michael Meyer, Jacalyn McHugh, Craig A. Tork, Antonio V. Hayes, Clive N. Svendsen · 2009 · Experimental Neurology
  36. Purkinje Cell Degeneration and Motor Coordination Deficits in a New Mouse Model of Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay
    Man Ding, Chao Weng, Shanghua Fan, Qian Cao, Zuneng Lu · 2017 · Frontiers in Molecular Neuroscience
  37. Expression of the axon‐guidance protein receptor Neuropilin 1 is increased in the spinal cord and decreased in muscle of a mouse model of amyotrophic lateral sclerosis
    Sonja Körner, Nadine Thau‐Habermann, Ekaterini Kefalakes, Franziska Bursch, Susanne Petri · 2018 · European Journal of Neuroscience
  38. The Contribution of TNFα to Synaptic Plasticity and Nervous System Function
    David Stellwagen · 2010 · Advances in experimental medicine and biology
  39. Effects of RAGE inhibition on the progression of the disease in hSOD1<sup>G93A</sup> ALS mice
    Liu, Liping, Killoy, Kelby M., Vargas, Marcelo R., Yamamoto, Yasuhiko, Pehar, Mariana · 2020 · Pharmacology Research &amp; Perspectives
  40. Desloratadine alleviates ALS-like pathology in hSOD1G93A mice via targeting 5HTR2A on activated spinal astrocytes
    Jian Lu, An-xu He, Zhuo-ying Jin, Meng Zhang, Zhongxin Li, Fan Zhou, Lin Ma, Hong-ming Jin, Jiaying Wang, Xu Shen · 2024 · Acta Pharmacologica Sinica
  41. The BCL-2 family protein Bid is critical for pro-inflammatory signaling in astrocytes
    Hans‐Georg König, Karen S. Coughlan, Sinead M. Kinsella, Bridget A. Breen, Jochen H.M. Prehn · 2014 · Neurobiology of Disease
  42. Friends Turn Foe—Astrocytes Contribute to Neuronal Damage in NeuroAIDS
    Hriday Shanker Pandey, Pankaj Seth · 2019 · Journal of Molecular Neuroscience
  43. Brain Protease Activated Receptor 1 Pathway: A Therapeutic Target in the Superoxide Dismutase 1 (SOD1) Mouse Model of Amyotrophic Lateral Sclerosis
    Efrat Shavit Stein, Ihab Abu Rahal, Doron Bushi, Orna Gera, Roni Sharon, Shany Guly Gofrit, Lea Pollak, Ekaterina Mindel, Nicola Maggio, Yoel Kloog et al. · 2020 · International Journal of Molecular Sciences
  44. Stem Cell Models and Gene Targeting for Human Motor Neuron Diseases
    Yashashree Karpe, Zhen-Yu Chen, Xue-Jun Li · 2021 · Pharmaceuticals
  45. Astrocyte‐targeting RNA interference against mutated superoxide dismutase 1 induces motoneuron plasticity and protects fast‐fatigable motor units in a mouse model of amyotrophic lateral sclerosis
    Cylia Rochat, Nathalie Bernard‐Marissal, Emma Källstig, Sylvain Pradervand, Florence Evelyne Perrin, Patrick Aebischer, Cédric Raoul, Bernard Laurent Schneider · 2022 · Glia
  46. Boundary Cap Neural Crest Stem Cells Promote Survival of Mutant SOD1 Motor Neurons
    Tanya Aggarwal, Jan Hoeber, Patrik Ivert, Svitlana Vasylovska, Elena N. Kozlova · 2017 · Neurotherapeutics
  47. Spatiotemporal control of mitochondrial network dynamics in astroglial cells
    Jana Göbel, Elisa Motori, Matteo Bergami · 2017 · Biochemical and Biophysical Research Communications
  48. Intramedullary spinal cord implantation of human CD34+umbilical cord-derived cells in ALS
    Anna-Lena Cordes, Kirsten Jahn, Ralf Hass, Kerstin Schwabe, Eva M. Weissinger, Arnold Ganser, Friedrich Götz, Reinhard Dengler, Joachim Kurt Krauss, Susanne Petri · 2011 · Amyotrophic Lateral Sclerosis
  49. The Role of the Neuro-Astro-Vascular Unit in the Etiology of Ataxia Telangiectasia
    Leenoy Meshulam, Ronit Galron, Sivan Kanner, Maurizio De Pittà, P. Bonifazi, M. M. Goldin, Dan Frenkel, Eshel Ben‐Jacob, Ari Barzilai · 2012 · Frontiers in Pharmacology
  50. Oral Neuroimmune Network and Mast Cells
    Virginia Karapanou, Duraisamy Kempuraj, Theoharis Constantin Theoharides · 2009 · European Journal of Inflammation
  51. Role of NCKAP1 in the Defective Phagocytic Function of Microglia-Like Cells Derived from Rapidly Progressing Sporadic ALS
    Min‐Young Noh, Min‐Soo Kwon, Ki‐Wook Oh, Minyeop Nahm, Jinseok Park, Young-Eun Kim, Chang‐Seok Ki, Hee Kyung Jin, Jae‐sung Bae, Seung Hyun Kim · 2023 · Molecular Neurobiology
  52. Serum cytokines profile changes in amyotrophic lateral sclerosis
    Chun‐Zuan Xu, Xiao Huan, Su-Shan Luo, Huahua Zhong, Chongbo Zhao, Yan Chen, Zhang‐Yu Zou, Sheng Chen · 2024 · Heliyon
  53. Defining (and blocking) neuronal death in Parkinson’s disease: Does it matter what we call it?
    Anna Memou, Lampros Dimitrakopoulos, Maria Kedariti, Michalis Kentros, Andriana Lamprou, Lilian Petropoulou-Vathi, Polytimi‐Eleni Valkimadi, Hardy J. Rideout · 2021 · Brain Research
  54. NR1D1 downregulation in astrocytes induces a phenotype that is detrimental to cocultured motor neurons
    Kelby M. Killoy, Benjamin A. Harlan, Mariana Pehar, Marcelo R. Vargas · 2022 · The FASEB Journal
  55. Severe congenital myasthenic syndromes caused by agrin mutations affecting secretion by motoneurons
    Arnaud Jacquier, Valérie Risson, Thomas Simonet, Florine Roussange, Nicolas Lacoste, Shams Ribault, Julien Carras, Julian Theuriet, Emmanuelle Girard, Isabelle Grosjean et al. · 2022 · Acta Neuropathologica
  56. Astrocytic K+ clearance during disease progression in amyotrophic lateral sclerosis
    Rebecca Stevenson, Evgeniia Samokhina, Armaan Mangat, Ilaria Rossetti, Sushmitha S. Purushotham, Chandra S. Malladi, John W. Morley, Yossi Buskila · 2023 · Glia
  57. Urinary biomarkers for amyotrophic lateral sclerosis: candidates, opportunities and considerations
    Mary‐Louise Rogers, David W Schultz, Vassilios Karnaros, Stephanie R. Shepheard · 2023 · Brain Communications
  58. TDP-43 modification in the hSOD1G93Aamyotrophic lateral sclerosis mouse model
    Mudan Cai, Kang‐Woo Lee, Sun‐Mi Choi, Eun Jin Yang · 2014 · Neurological Research
  59. Astrocytes: The Missing Link in Neurologic Disease?
    Chia-Ching John Lin, Benjamin Deneen · 2013 · Seminars in Pediatric Neurology
  60. SOD1 Mutations Causing Familial Amyotrophic Lateral Sclerosis Induce Toxicity in Astrocytes: Evidence for Bystander Effects in a Continuum of Astrogliosis
    Nicole Wallis, Chew Ling Lau, Manal A. Farg, Julie D. Atkin, Philip M. Beart, Ross D. O’Shea · 2017 · Neurochemical Research
  61. A Possible Role for Platelet-Activating Factor Receptor in Amyotrophic Lateral Sclerosis Treatment
    Marcelo R. S. Briones, Amanda M. Snyder, Renata C. Ferreira, Elizabeth B. Neely, James R. Connor, James Riley Broach · 2018 · Frontiers in Neurology
  62. Differences in the constituent fiber types contribute to the intermuscular variation in the timing of the developmental synapse elimination
    Young Il Lee · 2019 · Scientific Reports
  63. Targeting Glia for Treatment of Neurological Disease
    David A. Rempe, Maiken Nedergaard · 2010 · Neurotherapeutics
  64. Targeting the serotonergic system in the treatment of neurodegenerative diseases—emerging therapies and unmet challenges
    Alina Brüge, Evgeni G. Ponimaskin, Josephine Labus · 2025 · Pharmacological Reviews
  65. Amyotrophic lateral sclerosis
    Owen M. Peters, Robert H. Brown · 2022 · Elsevier eBooks
  66. Depletion of Mettl3 in cholinergic neurons causes adult-onset neuromuscular degeneration
    Georgia Dermentzaki, Mattia Furlan, Iris Tanaka, Tommaso Leonardi, Paola Rinchetti, Patricia M.S. Passos, Alliny Bastos, Yuna M. Ayala, Jacob H. Hanna, Serge Przedborski et al. · 2024 · Cell Reports
  67. Neuronal Circuit Dysfunction in Amyotrophic Lateral Sclerosis
    Andrea Salzinger, Vidya Ramesh, Shreya Das Sharma, Siddharthan Chandran, Bhuvaneish Thangaraj Selvaraj · 2024 · Cells
  68. Dissecting Motor Neuron Disease With Drosophila melanogaster
    Rachel Walters, John Manion, G. Gregory Neely · 2019 · Frontiers in Neuroscience
  69. Perturbations of the Proteome and of Secreted Metabolites in Primary Astrocytes from the hSOD1(G93A) ALS Mouse Model
    Roberto Stella, Raphael Severino Bonadio, Stefano Cagnin, Maria Lina Massimino, Alessandro Bertoli, Caterina Peggion · 2021 · International Journal of Molecular Sciences
  70. Models for IGHMBP2-associated diseases: an overview and a roadmap for the future
    Weronika Rzepnikowska, Andrzej Kochański · 2021 · Neuromuscular Disorders
  71. Amyotrophic lateral sclerosis models derived from human embryonic stem cells with different superoxide dismutase 1 mutations exhibit differential drug responses
    Takehisa Isobe, Norie Tooi, Norio Nakatsuji, Kazuhiro Aiba · 2015 · Stem Cell Research
  72. Therapeutic potential of spinal GLP-1 receptor signaling
    Dongao Zhang, Gang Lv · 2018 · Peptides
  73. Analysis of Neuroprotective Effects of Valproic Acid on Primary Motor Neurons in Monoculture or Co-cultures with Astrocytes or Schwann Cells
    Daniela Ragancokova, Klaus Jahn, Alexandra Kotsiari, Friedrich Schlesinger, Kirsten Haastert‐Talini, Martin Stangel, Susanne Petri, K Krampfl · 2009 · Cellular and Molecular Neurobiology
  74. Pyruvate dehydrogenase kinase 2 knockdown restores the ability of amyotrophic lateral sclerosis ‐linked SOD1G93A rat astrocytes to support motor neuron survival by increasing mitochondrial respiration
    Ernesto Miquel, Rosalía Villarino, Laura Martínez Palma, Adriana Cassina, Patricia Cassina · 2024 · Glia
  75. Trasplante de células troncales como terapia para la esclerosis lateral amiotrófica. Una mirada crítica
    Bernardita Soler, Ricardo Fadić, Rommy von Bernhardi M. · 2011 · Revista de Neurología
  76. Embryonic and induced pluripotent stem cell differentiation as a tool in neurobiology
    Vassiliki Nikoletopoulou, Nektarios Tavernarakis · 2012 · Biotechnology Journal
  77. TIMP-1 couples RhoK activation to IL-1β-induced astrocyte responses
    Kasey M. Johnson, Stephen J. Crocker · 2015 · Neuroscience Letters
  78. Increased motor neuron resilience by small molecule compounds that regulate IGF-II expression
    Teresia M. Osborn, Jonathan A. Beagan, Ole Isacson A · 2017 · Neurobiology of Disease
  79. Motoneuron Disease
    Michael Sendtner · 2014 · Handbook of experimental pharmacology
  80. Motor neuron-derived induced pluripotent stem cells as a drug screening platform for amyotrophic lateral sclerosis
    Mariana A. Amorós, Esther Sue Choi, Axel Helmut Rulf Cofré, Nikolay V. Dokholyan, Marcelo Duzzioni · 2022 · Frontiers in Cell and Developmental Biology
  81. Regional differences in the inflammatory and heat shock response in glia: implications for ALS
    Benjamin E. Clarke, Rebecca San Gil, Jing Yip, Bernadett Kalmár, Linda Greensmith · 2019 · Cell Stress and Chaperones
  82. Somatic and axonal LIGHT signaling elicit degenerative and regenerative responses in motoneurons, respectively
    Belkacem Otsmane, Anice Moumen, Julianne Aebischer, Emmanuelle Coque, Chamroeun Sar, Claire Sunyach, Céline Salsac, Jean Valmier, Sara Salinas, Mélissa Bowerman et al. · 2014 · EMBO Reports
  83. Glial-restricted precursors as potential candidates for ALS cell-replacement therapy
    Ewa Kruminis-Kaszkiel, Joanna Wojtkiewicz, Wojciech Maksymowicz · 2014 · Acta Neurobiologiae Experimentalis
  84. Skeletal myotubes expressing ALS mutant SOD1 induce pathogenic changes, impair mitochondrial axonal transport, and trigger motoneuron death
    Pablo Martínez, Mónica Silva, Sebastián Abarzúa, María Florencia Tevy, Enrique Jaimovich, Martha Constantine‐Paton, Fernando J. Bustos, Brigitte van Zundert · 2024 · Molecular Medicine
  85. Inflammatory cytokines disrupt astrocyte exosomal HepaCAM-mediated protection against neuronal excitotoxicity in the SOD1G93A ALS model
    Shijie Jin, Yang Tian, Jonathan Hacker, Xuan Chen, Marcela Bertolio, Caroline R. Reynolds, Rachel Jarvis, Jingwen Hu, Vanessa Promes, Dilara Ozge Halim et al. · 2024 · Science Advances
  86. Novel therapeutic targets for amyotrophic lateral sclerosis: ribonucleoproteins and cellular autonomy
    Yiran Wang, Rickie Patani · 2020 · Expert Opinion on Therapeutic Targets
  87. Dysregulated expression of death, stress and mitochondrion related genes in the sciatic nerve of presymptomatic SOD1G93A mouse model of Amyotrophic Lateral Sclerosis
    Chrystian Junqueira Alves, Jéssica Ruivo Maximino, Gerson Chadi · 2015 · Frontiers in Cellular Neuroscience
  88. Neuroprotective and Angiogenic Effects of Bone Marrow Transplantation Combined with Granulocyte Colony-Stimulating Factor in a Mouse Model of Amyotrophic Lateral Sclerosis
    Yasuyuki Ohta, Makiko Nagai, Kazunori Miyazaki, Nobuhito Tanaka, Hiromi Kawai, Takafumi Mimoto, Nobutoshi Morimoto, Tomoko Kurata, Yoshio Ikeda, Tohru Matsuura et al. · 2011 · Cell Medicine
  89. The Emerging Role of the Major Histocompatibility Complex Class I in Amyotrophic Lateral Sclerosis
    Gabriela Bortolança Chiarotto, Giovanni Nardo, Maria Chiara Trolese, Marcondes C. França, Caterina Bendotti, Alexandre Leite Rodrigues de Oliveira · 2017 · International Journal of Molecular Sciences
  90. Muscle secretion of toxic factors, regulated by miR126-5p, facilitates motor neuron degeneration in amyotrophic lateral sclerosis
    Roy Maimon, Eran Perlson · 2019 · Neural Regeneration Research
  91. Astragaloside IV and echinacoside benefit neuronal properties via direct effects and through upregulation of SOD1 astrocyte function in vitro
    Yang Tian, Shijie Jin, Vanessa Promes, Xuemei Liu, Yunling Zhang · 2020 · Naunyn-Schmiedeberg s Archives of Pharmacology
  92. NMR-Guided Design of Potent and Selective EphA4 Agonistic Ligands
    Carlo Baggio, Anna O. Kulinich, Cassandra N. Dennys, Rochelle Rodrigo, Kathrin Meyer, Iryna M. Ethell, Maurizio Pellecchia · 2021 · Journal of Medicinal Chemistry
  93. Transcription Factor Programming of Human Pluripotent Stem Cells to Functionally Mature Astrocytes for Monocultures and Cocultures with Neurons
    Ella Quist, Henrik Ahlenius, Isaac Canals · 2021 · Methods in molecular biology
  94. Early upregulation of cytosolic phospholipase A2α in motor neurons is induced by misfolded SOD1 in a mouse model of amyotrophic lateral sclerosis
    Yafa Fetfet Malada-Edelstein, Yulia Solomonov, Nurit Hadad, Leenor Alfahel, Adrian Israelson, Rachel Lévy · 2021 · Journal of Neuroinflammation
  95. Superoxide Dismutase and Oxidative Stress in Amyotrophic Lateral Sclerosis
    Mara Clara, N. Cassandra, Fabian H., G. Alvaro · 2013 · InTech eBooks
  96. ALS associated mutant SOD1 impairs the motor neurons and astrocytes and wild type astrocyte secreted-factors reverse the
    Thangavelu Soundara Rajan, Prem Prakash Tripathi, Upasna Arya, Himanshu K. Mishra, Jamuna R. Subramaniam · 2011 · Annals of Neurosciences
  97. Towards an integrated approach for understanding glia in Amyotrophic Lateral Sclerosis
    Stanisław Majewski, Pierre Klein, Séverine Boillée, Benjamin E. Clarke, Rickie Patani · 2024 · Glia
  98. Parkinson-like wild-type superoxide dismutase 1 pathology induces nigral dopamine neuron degeneration in a novel murine model
    Amr H. Abdeen, Benjamin Guy Trist, Sara Nikseresht, Richard Harwood, Stéphane Roudeau, Benjamin Darcy Rowlands, Fabian Kreilaus, Veronica Cottam, David Mor, Miriam Richardson et al. · 2025 · Acta Neuropathologica
  99. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons
    Sara D. Qi, Paul D. Smith, Peter Choong · 2012 · ANZ Journal of Surgery
  100. Aberrant CHCHD2-associated mitochondriopathy in Kii ALS/PDC astrocytes
    Nicolas Leventoux, Satoru Morimoto, Mitsuru Ishikawa, Shiho Nakamura, Fumiko Ozawa, Reona Kobayashi, Hirotaka Watanabe, Sopak Supakul, Satoshi Okamoto, Zhi Zhou et al. · 2024 · Acta Neuropathologica